WBA240927C6500
- 6.50
- 0.000.00%
Walgreens Boots Alliance Newsroom
Barclays Maintains Walgreens Boots Alliance(WBA.US) With Sell Rating, Maintains Target Price $7
Walgreens Boots Alliance: Liquidity Concerns Sustain Sell Rating
Walgreens Boots Alliance Is Maintained at Buy by TD Cowen
Walgreens Boots Alliance Analyst Ratings
TD Cowen Maintains Walgreens Boots Alliance(WBA.US) With Buy Rating, Cuts Target Price to $16
TD Cowen Cuts Price Target on Walgreens Boots Alliance to $16 From $22
Analysts Offer Insights on Healthcare Companies: Walgreens Boots Alliance (WBA), Belite Bio, Inc. ADR (BLTE) and Protagonist Therapeutics (PTGX)
Barclays Maintains Walgreens Boots Alliance(WBA.US) With Sell Rating, Maintains Target Price $7
Barclays Sticks to Its Sell Rating for Walgreens Boots Alliance (WBA)
BofA Securities Maintains Walgreens Boots Alliance(WBA.US) With Sell Rating, Cuts Target Price to $7.5
B of A Securities Maintains Underperform on Walgreens Boots Alliance, Lowers Price Target to $7.5
Walgreens Boots Alliance: Hold Rating Maintained Amidst Ongoing Headwinds and Financial Challenges
Walgreens Boots Alliance Is Maintained at Overweight by JP Morgan
Walgreens Boots Alliance Analyst Ratings
J.P. Morgan Maintains Walgreens Boots Alliance(WBA.US) With Buy Rating, Cuts Target Price to $15
Analysts' Opinions Are Mixed on These Healthcare Stocks: Walgreens Boots Alliance (WBA), 2seventy Bio (TSVT) and Repare Therapeutics (RPTX)
Evercore ISI Sticks to Their Hold Rating for Walgreens Boots Alliance (WBA)
Evercore ISI Lowers Price Target on Walgreens Boots Alliance to $7.50 From $10, Keeps In Line Rating
Walgreens Boots Alliance (WBA) Receives a Sell From Barclays
Barclays Maintains Walgreens Boots Alliance(WBA.US) With Sell Rating, Maintains Target Price $7